[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"NIN Institute\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100560387","effect-of-a-specialized-oral-supplement-on-nutritional-status-and-quality-of-life-in-non-dialysis-ckd-100560387",false,"NCT06576479","Effect of a Specialized Oral Supplement on Nutritional Status and Quality of Life in Non-dialysis CKD","Validation of the Therapeutic Effect and Safety of a Specialized Oral Supplement on the Nutritional Status and Quality of Life in Patients with Chronic Kidney Disease Without Replacement Therapy: (Grade G3a, G3b, G4 and G5)","Inclusion Criteria:\n\n* Patients over 18 years of age\n* Patients with diabetic kidney with eGFR \\\u003C60 ml \u002F min \u002F 1.73m2 and ≥15 ml \u002F min \u002F 1.73m2, (stage G3a, G3b and G4 respectively)\n* Patients with protein energy expenditure (defined by serum albumin \\\u003C 3.8 g\u002Fdl)\n* Patients with protein energy expenditure (defined by 24-hour recall less than a dietary protein intake \\\u003C0.6 g\u002Fkg\u002Fd or have a consumption \\\u003C25 kcal\u002Fkg\u002Fd\n* Patients who can read and write (or primary caregiver)\n* Domicile within the metropolitan area\n\nExclusion Criteria:\n\n* Previous hospitalizations in the last month\n* Patients with serious complications (chronic infection, septicemia, cancer, HIV, Alzheimer's, uncontrolled heart failure, liver failure, cerebrovascular syndrome, malabsorption syndrome, or allergy to any ingredient in the nutritional supplement)\n* Patients with actual consumption of food supplements and \u002F or keto analogues.\n\nElimination Criteria:\n\n* Failure to attend nutritional assessment and biochemical testing at baseline, 2 months, and end of the study.\n* Failure to take the supplement \\>10% (\\>12 failed doses).\n* Diagnosis of any comorbidity during the intervention period.\n* Initiation of replacement therapy.\n* Identification of adverse effects.\n* Withdrawal of voluntary participation by the patient.\n* Death.","ALL","18 Years","90 Years",{"count":20,"type":21},50,"ESTIMATED","INTERVENTIONAL",[24],"NA","Patients whit chronic kidney disease (CKD) there is a high prevalence of nutritional disorders and negative changes in body composition, which is strongly associated with an increased risk of morbidity and mortality.",[27,28],"Chronic Kidney Diseases","Protein-Energy Malnutrition",[30,31,32],"chronic kidney disease","PEW","nutrition","RECRUITING","2024-12-16",{"date":36,"type":37},"2024-12-18","ACTUAL",{"date":39,"type":37},"2018-07-10",{"date":41,"type":21},"2025-03",{"name":43,"class":44},"NIN Institute","INDUSTRY",""]